Baptist Medical Center Princeton

Birmingham, Alabama 35211

0 studies enrolling now · 17 studies all time

What they study most

Atherosclerosis, Cardiac Arrhythmia, Cardiac Resynchronization Therapy, Cardiovascular Disease, Cardiovascular Diseases, Carotid Artery Disease, Coronary Artery Disease, Coronary Artery Restenosis, Coronary Artery Stenosis, Coronary Disease, Coronary Restenosis, Coronary Stenosis

Studies at this site

• Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation — Running, not enrolling
• Optisure Lead Post Approval Study — Stopped early
• EnSite Precision Observational Study — Completed
• ABSORB III Randomized Controlled Trial (RCT) — Completed
• Precision Event Monitoring for Patients With Heart Failure Using HeartLogic — Completed
• The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices — Completed
• The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions — Completed
• The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s) — Completed
• Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II) — Completed
• Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass — Stopped early
• Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication — Completed
• TAXUS PERSEUS Workhorse — Completed
• SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) — Completed
• A Carotid Stenting Boston Scientific Surveillance Program — Completed
• Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis — Completed
• Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stents to Treat De Novo Coronary Lesions — Completed
• Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts — Completed